ArticleEndocrine2025
Qualitative and quantitative CEUS assessment for differential diagnosis in thyrotoxicosis: destruction vs. hyperfunction.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Conventional ultrasound combined with contrast-enhanced ultrasound for differentiating benign and malignant thyroid nodules.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThyrotoxicosis results from either thyroid hyperfunction, as seen in Graves' disease, or tissue destruction, as in subacute thyroiditis (SAT). Differential diagnosis is essential but can be challenging, with thyroid scintigraphy traditionally used to distinguish between these types. This study investigates the potential of Contrast-Enhanced Ultrasound (CEUS) to provide a non-invasive alternative for differentiating hyperfunction and destructive thyroid disease.
methodsIn a prospective study, 42 patients with untreated thyrotoxicosis were evaluated using CEUS to analyze both qualitative and quantitative perfusion parameters.
resultsGroup 1 included 20 patients with Graves' disease, while Group 2 comprised 22 patients with destructive thyrotoxicosis (SAT, Hashitoxicosis, postpartum thyroiditis, and iatrogenic cases). Significant differences were observed in CEUS parameters between the two groups. Hyperfunction cases showed higher Peak Intensity (PKI), Area Under Curve (AUC), Wash-in AUC (WiAUC), Wash-out AUC (WoAUC), and Mean Time-Intensity Curve (mTIC), while Rise Time (RT) and Time to Peak (TTP) were prolonged in the destruction group. Strong correlations with hyperfunction were observed for PKI, AUC, WoAUC, and mTIC. Optimal cut-off values of AUC > 1991, WoAUC > 1876, and mTIC > 10 achieved 100% sensitivity and specificity for identifying hyperfunction.
conclusionThis preliminary study suggests that CEUS, with its quantitative and qualitative assessments, could be a valuable tool in the non-invasive differential diagnosis of thyrotoxicosis, potentially reducing the need for scintigraphy and enabling rapid and accurate treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.